Homepage

Cross Country Healthcare, Inc.

CCRN NASDAQ Categories PDF
Healthcare · Medical - Care Facilities · United States · Updated May 11, 1:52pm
$13.13
Price
$424.3M
Market Cap
9,605
Employees
0.36
Beta
Kevin Cronin Clark
CEO
Business Description

Cross Country Healthcare, Inc. provides talent management and other consultative services for healthcare clients in the United States. The company operates in two segments, Nurse and Allied Staffing and Physician Staffing. The Nurse and Allied Staffing segment offers traditional staffing, including temporary and permanent placement of travel nurses and allied professionals, local nurses, and allied staffing; staffing solutions for registered nurses, licensed practical nurses, certified nurse assistants, practitioners, pharmacists, and other allied professionals on per diem and short-term assignments; and clinical and non-clinical professionals on long-term contract assignments, as well as workforce solutions, including MSP, RPO, and consulting services. It also provides retained search services for healthcare professionals, as well as contingent search and recruitment process outsourcing services. This segment serves public and private acute care and non-acute care hospitals, government facilities, local and national healthcare plans, managed care providers, public and charter schools, outpatient clinics, ambulatory care facilities, physician practice groups, and other healthcare providers under the Cross Country brand. The Physician Staffing segment provides physicians in various specialties, certified registered nurse anesthetists, nurse practitioners, and physician assistants under the Cross Country Locums brand as independent contractors on temporary assignments at various healthcare facilities, such as acute and non-acute care facilities, medical group practices, government facilities, and managed care organizations. The company was founded in 1986 and is headquartered in Boca Raton, Florida.

Business History
Price Overview
Last updated: May 11, 2026 1:52pm (just now)
$13.13
-0.05 (-0.40%)
Day Range
$13.12 – $13.16
52-Week Range
$7.43 – $14.99
50-Day MA
$9.83
200-Day MA
$10.81
Volume
434,666.16
Analyst Price Targets
Low $8.65
Consensus $10.61
High $14.00
(7 analysts)
Share Structure
Outstanding 32,318,700.00
Float 29,808,021.00
Free Float 92.2%
High free float — 92.2% of shares trade freely, ~7.8% held by insiders/institutions
Very liquid — most shares trade freely. Low insider ownership can mean less management alignment, but makes large position sizing straightforward.
Price History (1 Year)
Revenue & Net Income Trend
The directional story — useful even when net income is negative.
Revenue
The top line — total sales before any costs or taxes are subtracted. A measure of how much business the company is doing.
Net Income
The bottom line — profit left after subtracting all expenses, interest, and taxes from revenue. Reflects accounting profitability, but includes non-cash items like depreciation, so it isn't the same as cash earned.
Operating Cash Flow
The real cash generated by the day-to-day business — selling products, paying suppliers, collecting from customers. Calculated from net income by adding back non-cash items and adjusting for timing (unpaid bills, unsold inventory). When OCF consistently lags net income, the reported profit may not be converting to real money.
Period Revenue Net Income Net Margin YoY/QoQ
Key Metrics
API Direct from provider CALC Derived from statements
P/E Ratio (Price per dollar of earnings)
CALC
Stock Price / EPS (Diluted)
-4.48
Stock Price: $13.13
EPS (Diluted): -2.93
P/B Ratio (Price vs net asset value)
API
Stock Price / Book Value Per Share
0.81
Stock Price: $13.13
Total Equity: $322.82M
Shares: 32,409,000
EV/EBITDA (Total value vs operating profit)
API
Enterprise Value / EBITDA
30.16
Market Cap: $424.25M
Total Debt: $1.16M
Cash: $108.74M
EBITDA: $13.33M
Enterprise Value (Takeover price (cap + debt - cash))
API
Market Cap + Total Debt - Cash
$156.1M
Market Cap: $424.25M
Total Debt: $1.16M
Cash: $108.74M
Gross Margin (Revenue left after direct costs)
API
Gross Profit / Revenue
18.7%
Gross Profit: $196.78M
Revenue: $1.05B
Operating Margin (Revenue left after all operations)
API
Operating Income / Revenue
-0.3%
Operating Income: -$3.46M
Revenue: $1.05B
Net Margin (Revenue left as actual profit)
API
Net Income / Revenue
-9.0%
Net Income: -$94.85M
Revenue: $1.05B
ROE (Profit from shareholder equity)
API
Net Income / Total Equity
-27.1%
Net Income: -$94.85M
Total Equity: $322.82M
ROIC (Profit from all invested capital)
API
NOPAT / Invested Capital
-1.2%
Operating Income: -$3.46M
Tax Rate: -13.6%
Equity: $322.82M
Total Debt: $1.16M
Cash: $108.74M
Current Ratio (Can it pay short-term bills)
API
Current Assets / Current Liabilities
3.78
Current Assets: $293.59M
Current Liabilities: $77.76M
Debt/Equity (Leverage — debt vs equity)
CALC
Total Debt / Total Equity
0.00
Short-Term Debt: $1.16M
Long-Term Debt: $0.00
Total Debt: $1.16M
Total Equity: $322.82M
Rev/Share (Top-line per share)
CALC
Revenue / Shares Outstanding
$32.53
Revenue: $1.05B
Shares: 32,409,000
Book Value/Share (Net assets per share)
CALC
(Total Assets - Total Liabilities) / Shares
$9.96
Total Equity: $322.82M
Shares: 32,409,000
FCF/Share (Real cash generated per share)
CALC
(Operating Cash Flow + CapEx) / Shares
$1.24
Operating CF: $48.25M
CapEx: -$8.16M
Shares: 32,409,000
CapEx is negative (outflow) — added to OCF to get FCF
Div Yield (Annual income from holding)
API
Last Annual Dividend / Stock Price
0.0%
Last Dividend: N/A
Stock Price: $13.13
Payout Ratio (Earnings paid out as dividends)
Dividends Paid / Net Income
—
Dividends Paid: N/A
Net Income: -$94.85M
Dividends paid not available in cash flow statement
Industry Benchmarks
Compares CCRN against LLM-researched typical ranges for its industry. One research call per industry, cached indefinitely — every stock in the same industry reuses the same baseline.
Deep Analysis

Pre-flight intelligence scans the company first, then routes to the right analytical methods.

0 Company Classification — What type of company is this?
1 Industry Landscape — Where is the industry headed?
2 Company Momentum — Where is this company trending?
3 Forward Projection — 1Y & 2Y projected metrics (requires Layer 1 + 2)
4a DCF Valuation — Present value of future cash flows
4b Earnings Power Value — Floor value — worth with zero growth
4c Anchored PE — Industry PE adjusted for growth differential
4d Reverse DCF — What growth is the market pricing in?
4e Revenue-Based DCF — For growth/narrative companies (skip if mature earner)
4f Anchored P/S — Price-to-Sales peer comparison (skip if mature earner)
4g Scenario Analysis — Bull / Base / Bear (skip if mature earner)
4h Dividend Discount Model — For dividend/income stocks only
4i Book Value Analysis — For deep value / turnaround stocks only
4j Insider Activity — Are insiders buying or selling?
4f Cash Flow Quality — How trustworthy is the FCF?
4g Debt Maturity Risk — Can it handle its debt?
4h Macro Environment — Rates, market valuation, volatility
4i Sector Intelligence — How does this company compare within its sector?
4j Revenue Confidence — How reliable is the growth projection?
4k Sensitivity Analysis — How fragile is the fair value estimate?
4l Sector Demand Cycle — Is the sector in a boom, steady state, or contraction?
5 AI Investigation — Adaptive research engine (Claude)
5b Thesis Evaluation — What does the market believe? (narrative/platform stocks only)
6 Valuation Synthesis — Weighted verdict from all methods (requires Layer 4)
Income Statement (Annual)
Metric 2021 2022 2023 2024 2025
Revenue $1.7B $2.8B $2.0B $1.3B $1.1B
Cost of Revenue $1.3B $2.2B $1.6B $1.1B $857.5M
Gross Profit $375.0M $624.5M $450.4M $274.3M $196.8M
Operating Expenses $235.7M $354.6M $337.7M $291.1M $200.2M
Operating Income $139.3M $269.9M $112.7M -$16.9M -$3.5M
Net Income $132.0M $186.0M $72.6M -$14.6M -$94.9M
EBITDA $154.6M $280.1M $129.3M $16.8M $13.3M
EPS $3.60 $5.09 $2.07 $-0.44 $-2.93
EPS (Diluted) — — — — —
Balance Sheet (Annual)
Metric 2021 2022 2023 2024 2025
Cash & Equivalents $1.0M $3.6M $17.1M $81.6M $108.7M
Total Current Assets $508.3M $675.7M $415.2M $335.0M $293.6M
Total Assets $732.8M $947.8M $679.3M $589.3M $449.0M
Current Liabilities $199.8M $271.6M $148.6M $120.4M $77.8M
Long-Term Debt $176.4M $148.7M $0 $0 $0
Total Liabilities $435.3M $490.6M $205.9M $170.3M $126.1M
Total Equity $297.5M $457.2M $473.4M $419.0M $322.8M
Retained Earnings -$22.7M $165.7M $238.4M $218.1M $123.2M
Cash Flow (Annual)
Metric 2021 2022 2023 2024 2025
Operating Cash Flow -$85.6M $134.1M $248.5M $120.1M $48.3M
Capital Expenditure -$7.2M -$8.8M -$14.0M -$8.7M -$8.2M
Free Cash Flow -$92.8M $125.3M $234.5M $111.4M $40.1M
Acquisitions (net) -$26.9M -$35.1M $199,000 $0 $0
Debt Repayment — — — — —
Dividends Paid — — — — —
Stock Buybacks -$2.2M -$35.3M -$57.7M -$37.3M -$6.8M
Net Change in Cash $-564,000 $2.6M $13.5M $64.5M $27.1M
Analyst Estimates (Annual)
Metric 2027 2028 2029 2030
Revenue $1.0B
$1.0B – $1.0B
 $1.1B
$1.1B – $1.1B
 $1.1B
$1.1B – $1.2B
 $1.2B
$1.2B – $1.2B
EBITDA $57.4M
$56.3M – $58.0M
 $61.1M
$60.9M – $61.4M
 $64.2M
$63.2M – $65.2M
 $67.6M
$66.5M – $68.6M
Net Income $8.2M
$6.3M – $10.5M
 $12.0M
$11.7M – $12.2M
 $19.4M
$19.1M – $19.8M
 $33.4M
$32.7M – $34.1M
EPS — — — —
Growth Trends (YoY %)
Metric 2022 2023 2024 2025
Revenue Growth +67.2% -28.0% -33.5% -21.6%
Gross Profit Growth +66.5% -27.9% -39.1% -28.2%
Operating Income Growth +93.7% -58.2% -115.0% +79.5%
Net Income Growth +40.9% -60.9% -120.0% -551.6%
EBITDA Growth +81.2% -53.8% -87.0% -20.5%
Insider Trading (Recent)
Date Insider Type Shares Price Value
2026-03-31 Krug Marc S. A-Award 21,024.00 $0.00 $0
2026-03-31 Krug Marc S. F-InKind 1,123.00 $9.40 $10,556
2026-03-31 Krug Marc S. F-InKind 1,339.00 $9.40 $12,587
2026-03-31 Hawkins Amiee Lin A-Award 15,958.00 $0.00 $0
2026-03-31 Hawkins Amiee Lin F-InKind 583.00 $9.40 $5,480
2026-03-31 Hawkins Amiee Lin F-InKind 695.00 $9.40 $6,533
2026-03-31 Clark Kevin Cronin A-Award 138,963.00 $0.00 $0
2026-03-31 Burns William J. A-Award 47,873.00 $0.00 $0
2026-03-31 Burns William J. F-InKind 2,423.00 $9.40 $22,776
2026-03-31 Burns William J. F-InKind 2,890.00 $9.40 $27,166
2026-03-31 Ball Susan E A-Award 33,644.00 $0.00 $0
2026-03-31 Ball Susan E F-InKind 1,689.00 $9.40 $15,877
2026-03-31 Ball Susan E F-InKind 2,014.00 $9.40 $18,932
2026-03-31 Veizaga Marvin A-Award 9,043.00 $0.00 $0
2026-03-31 Veizaga Marvin F-InKind 501.00 $9.40 $4,709
2026-03-31 Veizaga Marvin F-InKind 437.00 $9.40 $4,108
2026-03-10 Veizaga Marvin 0.00 $0.00 $0
2026-03-11 McDonald Colin Patrick S-Sale 6,200.00 $9.70 $60,146
2026-01-19 Hawkins Amiee Lin 0.00 $0.00 $0
2025-03-31 Ball Susan E F-InKind 1,740.00 $14.89 $25,909
Community AI Feedback
Sign in to Contribute
No community reviews yet for CCRN. Be the first — export the analysis to your AI and contribute back.
My Notes personal — only you see this
Data via Financial Modeling Prep · Cached for performance · fmp
v1.1.193 · 1946f027 · 2026-05-08 18:57:27